Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.34 |
| ▸ | USP14 | P54578 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13956895 | 1.00 | DNM1 (0.36) | DNM1POLBMAPTPDE10AALDH1A1 | |
| SCHEMBL4251581 | 0.95 | DNM1 (0.39) | DNM1POLBMAPTPDE10AALDH1A1 | |
| SCHEMBL14845769 | 0.93 | ALDH1A1 (0.41) | DNM1POLBMAPTPDE10AALDH1A1 | |
| SCHEMBL2721451 | 0.93 | ALDH1A1 (0.41) | DNM1POLBMAPTPDE10AALDH1A1 | |
| SCHEMBL4252836 | 0.90 | DNM1 (0.39) | DNM1POLBMAPTPDE10AALDH1A1 | |
| SCHEMBL356742 | 0.90 | ALDH1A1 (0.44) | DNM1POLBMAPTPDE10AALDH1A1 | |
| SCHEMBL18674305 | 0.90 | ALDH1A1 (0.44) | POLBMAPTALDH1A1MAPK1TSHR | |
| SCHEMBL38654780 | 0.90 | ALDH1A1 (0.44) | POLBMAPTALDH1A1MAPK1TSHR | |
| SCHEMBL29447739 | 0.89 | POLB (0.41) | POLBMAPTMAPK1TSHRGAA | |
| SCHEMBL12544709 | 0.89 | POLB (0.41) | POLBMAPTMAPK1TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-12 | — | — | US | disclosed |
| EP-1641894-B1 | NOVEL MATERIALS FOR ELECTROLUMINESCENCE | MERCK PATENT GMBH (DE) | 2009-01-21 | — | — | EP | disclosed |
| US-20060284140-A1 | Novel materials for electroluminescence | MERCK PATENT GMBH (DE) | 2006-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | NAT1, SAT1, RIF1 | DNM1 1173/4885POLB 2158/4885MAPT 1378/4885 |
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | DNM1 2017/4885POLB 2108/4885MAPT 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.